Skip to main content
Clinical Trials/NCT00595634
NCT00595634
Terminated
Not Applicable

Intramedullary Nailing for Treatment of Unstable InterTrochanteric (INTUIT) Hip Fracture Outcome Study.

Smith & Nephew, Inc.5 sites in 1 country92 target enrollmentJanuary 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Unstable Intertrochanteric Hip Fractures
Sponsor
Smith & Nephew, Inc.
Enrollment
92
Locations
5
Primary Endpoint
Mobility function as defined by the Timed Up & Go (TUG) frequency.
Status
Terminated
Last Updated
12 years ago

Overview

Brief Summary

The primary objective of this study is to characterize patients' course of recovery in the year following the initial surgery for unstable intertrochanteric hip fractures treated with the InterTAN intramedullary hip screw device. This will be done by collecting patient outcome measures of health related quality of life and functional status including return to normal gait. Secondary objectives are to document any adverse events associated with the procedure, and to analyze differences in recovery due to differences in age, gender, co-morbidities, nutrition, residence and ambulation status, and use of mobility aids.

Registry
clinicaltrials.gov
Start Date
January 2008
End Date
November 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Unilateral unstable intertrochanteric hip fracture without other lower extremity fractures.
  • Community and household ambulators with or without assistive devices.
  • Age 50 years or greater.

Exclusion Criteria

  • Stable intertrochanteric hip fracture.
  • Bilateral or two or more lower extremity fractures.
  • Non-functional ambulators or non-ambulators.
  • Age less than 50 years.

Outcomes

Primary Outcomes

Mobility function as defined by the Timed Up & Go (TUG) frequency.

Time Frame: Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months

Secondary Outcomes

  • EuroQol(Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months)
  • Lower Extremity Activity Scale(Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months)
  • Visual Analogue Score (VAS)(Baseline, Post-Operatively at 2 Weeks, 6 Weeks, 3 Months, 6 Months and 12 Months)
  • Adverse Event(When necessary)

Study Sites (5)

Loading locations...

Similar Trials